申请人:Gravestock Barry Michael
公开号:US20050043374A1
公开(公告)日:2005-02-24
Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof,
wherein, for example, HET is an N-linked 5-membered, fully or partially unsaturated heterocyclic ring, or HET is an N-linked 6-membered di-hydro-heteroaryl ring;
Q is, for example, Q1 or Q2:
wherein R
2
and R
3
are independently hydrogen or fluoro;
T is, for example, (TAa1) or (TAa2):
wherein R
4h
and R
5h
are independently selected, for example, from hydrogen, halo, trifluoromethyl, cyano, nitro and (1-4C)alkoxy; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
化合物的公式(I),或其药学上可接受的盐,或其体内可水解的酯,其中,例如,HET是一个N-连接的5元、完全或部分不饱和的杂环环,或者HET是一个N-连接的6元双氢杂环芳基环;Q是,例如,Q1或Q2:其中R2和R3独立地是氢或氟;T是,例如,(TAa1)或(TAa2):其中R4h和R5h独立地从氢、卤、三氟甲基、氰、硝基和(1-4C)烷氧基中选取,可用作抗菌剂;并描述了制造它们的过程和含有它们的制药组合物。